The determination of recombinant adenoviral (rAd) infectivity and p53 protein expression is important for the evaluation of rAd vectors containing the p53 gene (rAd-CMV-p53) for gene therapy. We have previously reported that rAd5-CMV-p53 vectors can be assessed for infectivity and concomitant p53 pr
Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin)
β Scribed by Dr. Keiji Kawamoto; Yasuhiro Wada; Hirofumi Kumazawa; Toshio Yamashita; Tadami Kumazawa; Hiroshi Matsumura
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 582 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-eight previously untreated patients with a histologically proved diagnosis of nasopharyngeal carcinoma were evaluated for in vivo cell kinetics before treatment by conventional radiation therapy. Thirty-seven tumors were analyzed by flow cytometry. Values of median potential doubling time (Tp
Flow cytometric measurement of the S-phase fraction (FCM-Sl may be clinically useful in human cancers to identify high-risk patients. However, its clinical application requires a methodologic standardization, a high feasibility, and the reproducibility of results within the same and among different
The authors report a prospective study on 88 samples of superficial lesions (lymph nodes, skin nodules, and breast tumors), performed by fine-needle aspiration cytology (FNAC) in 74 patients, allowing (i) morphologic analysis combined with immunophenotyping by flow cytometry (FCM) and (ii) a cytogen